We will perform an efficacy study of SRT1-1-mIgG1 in a mouse model of myelofibrosis. We will compare the effect to that of the ALK5 inhibitor galunisertib.
|Effective start/end date||6/8/18 → 7/31/19|
- Scholar Rock, Inc. (Prot #IS00008289)
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.